20595-1-AP
antibody from Proteintech Group
Targeting: POLR1A
DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20595-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20595-1-AP, RRID:AB_10949227
- Product name
- POLR1A antibody
- Antibody type
- Polyclonal
- Description
- POLR1A antibody (Cat. #20595-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma.
POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis.
PCDHGB7 inhibits the progression of triple-negative breast cancer by suppressing XRCC5/MYC-mediated ribosome biogenesis.
RECQ5 mediates pre-rRNA processing in nucleolus.
Calmodulin Triggers Activity-Dependent rRNA Biogenesis via Interaction with DDX21.
TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC.
RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination.
Qu Y, Pei X, Feng J, Yan X, Zhang L, Wang J, Yao X, Bian J, Gan Y, Gan H, Jiang X, Yang P, Cai M, Li L, Wu X, Jing W, Zhang C, Zhao J, Zhang H, Shi G, Zhou X, Ye D, Ding C
Research (Washington, D.C.) 2025;8:0859
Research (Washington, D.C.) 2025;8:0859
POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis.
Zhang T, Gao Y, Harhai M, Jourdain AA, Marti TM, Vassella E, Yang Z, Zhou Q, Dorn P, Peng RW
Redox biology 2025 Sep;85:103758
Redox biology 2025 Sep;85:103758
PCDHGB7 inhibits the progression of triple-negative breast cancer by suppressing XRCC5/MYC-mediated ribosome biogenesis.
Shan M, Bi H, Sun H, Li Y, Li Z, Wang Z, Dong J, Sang S, Ren L, Ye Y, Wang T, Volarević S, Su R, Zhang L, Zhang M, He Y, Zhang G, Li J, Li X
Clinical and translational medicine 2025 Sep;15(9):e70437
Clinical and translational medicine 2025 Sep;15(9):e70437
RECQ5 mediates pre-rRNA processing in nucleolus.
Ma Y, Yu X
Nucleic acids research 2025 Aug 11;53(15)
Nucleic acids research 2025 Aug 11;53(15)
Calmodulin Triggers Activity-Dependent rRNA Biogenesis via Interaction with DDX21.
Yang JL, Sun X, Shi JX, Cui QX, Cao XY, Wang KT, An MX, Wu SJ, Yang YL, Sun HZ, Zhao WD
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Aug 28;44(35)
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Aug 28;44(35)
TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC.
Wu C, Xia D, Wang D, Wang S, Sun Z, Xu B, Zhang D
Cancer science 2022 Feb;113(2):553-564
Cancer science 2022 Feb;113(2):553-564
RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination.
Liu S, Hua Y, Wang J, Li L, Yuan J, Zhang B, Wang Z, Ji J, Kong D
Cell 2021 Mar 4;184(5):1314-1329.e10
Cell 2021 Mar 4;184(5):1314-1329.e10
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The RPA1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human RPA1. This antibody recognizes human antigen. The RPA1 antibody has been validated for the following applications: ELISA, WB analysis.